Pluripotent Haematopoietic stem cells and Haematopoiesis
Register to Join Webinar
Topic: Pluripotent Haematopoietic stem cells and Haematopoiesis
Hematopoiesis is the process of circulating blood cells in the body. Hematopoiesis produces around 175 billion red cells, 70 billion granulocytes (neutrophils, eosinophils, and basophils) every day, and 175 billion platelets per day. Each day, the body generates billions of new blood cells, all of which are developed from a single hematopoietic stem cell. Colony-stimulating factors, cytokines, and cytokine receptors send signals that allow multipotential and mature hematopoietic cells to survive and proliferate.
These massive cell populations are the direct progeny of growing precursor cells, which come from a smaller pool of progenitor cells. The progenitor cells are derived from an even smaller pool of hematopoietic stem cells (HSCs), which are assumed to be primarily resting or non-dividing and capable of self-renewal (and thus maintain their numbers).
Speaker: Dr. Lipi Singh, PhD Dr Lipi Singh is the Vice President of Advancells Group in India. Dr Singh has over 18 years of expertise in the field of Stem Cell Biology and Regenerative Medicine, accomplished her postdoctoral research in Stem Cell Biology in 2011 at the City of Hope National Medical Centre & Beckman Research Centre, California, USA. She received an esteemed postdoctoral fellowship from the “California Institute of Regenerative Medicine, USA” for her work on pancreatic stem cells for replacement therapy of Type I Diabetes. She is also an active member (Clinical Fellow) of the American Academy of Anti-Aging Medicine in Florida, USA. She received her PhD in Pancreatology from the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh, India.
She has extensive experience in stem cell therapy, as well as product development and technology. The company successfully identified and purified hematopoietic and non-hematopoietic stem cells from a variety of sources, and banked them for future therapeutic purposes, under her leadership. She has a broad background in GMP-based cell production, as well as Quality Assurance and Regulatory Affairs in stem cell therapeutics and clinical studies. Her contributions in stem cell processing, banking, research, and therapies have garnered her national and international acclaim.
Presently, she is working with Advancells Group, India, to create a frontier of wellbeing through regenerative medicine, which is a pivotal necessity for health care worldwide. This encompasses overall health and endurance, as well as raising global awareness of “A new era of wellbeing through Regenerative Medicine”.
Webinar Date: 21st March, 2022
Webinar Time: 5:00 P.M. TO 6:00 P.M. IST